Pennsylvania · 2025-2026 Regular Session · Resolution
SR 230: A Resolution designating March 25, 2026, as "Autoimmune Hemolytic Anemia Awareness Day" in Pennsylvania.
In committee Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
SR 230 is a resolution introduced in the Pennsylvania Senate on February 27, 2026. According to its official title, it concerns: A Resolution designating March 25, 2026, as "Autoimmune Hemolytic Anemia Awareness Day" in Pennsylvania. Primary sponsor: Wayne Fontana (Democratic). It lists 13 additional sponsors. Most recent recorded action (February 27, 2026): Referred to Rules & Executive Nominations.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Sponsors
Sponsors by party (alphabetical): Democratic 9 · Republican 5
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Wayne Fontana | Primary sponsor | Democratic | Senate | 42 |
| Amanda Cappelletti | Co-sponsor | Democratic | Senate | 17 |
| Jay Costa | Co-sponsor | Democratic | Senate | 43 |
| Lynda Culver | Co-sponsor | Republican | Senate | 27 |
| Art Haywood | Co-sponsor | Democratic | Senate | 4 |
| Vincent Hughes | Co-sponsor | Democratic | Senate | 7 |
| John Kane | Co-sponsor | Democratic | Senate | 9 |
| Doug Mastriano | Co-sponsor | Republican | Senate | 33 |
| Kristin Phillips-Hill | Co-sponsor | Republican | Senate | 28 |
| Nick Pisciottano | Co-sponsor | Democratic | Senate | 45 |
| Steve Santarsiero | Co-sponsor | Democratic | Senate | 10 |
| Tina Tartaglione | Co-sponsor | Democratic | Senate | 2 |
| Elder Vogel | Co-sponsor | Republican | Senate | 47 |
| Judy Ward | Co-sponsor | Republican | Senate | 30 |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- Referred to Rules & Executive Nominations